Rangeley Capital »

Theravance Biopharma shares owned by Rangeley Capital

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7M 103k 16.23
2025-06-30 $372k 34k 11.03

More positions owned by Rangeley Capital

Liquidia Corporation Com New Put Option (LQDA)
Driven Brands Hldgs (DRVN)
Revolution Medicines (RVMD)
Prothena Corp SHS (PRTA)
Seaport Entmt Group Common Stock (SEG)
Warner Bros Discovery Com Ser A (WBD)
Grindr (GRND)
Delek Us Holdings (DK)
Arvinas Ord (ARVN)
Arbutus Biopharma (ABUS)
Echostar Corp Cl A (SATS)
Leggett & Platt (LEG)
Star Hldgs Shs Ben Int (STHO)
Full House Resorts (FLL)
Tripadvisor (TRIP)

View all positions for Rangeley Capital

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Vanguard Capital Management
Acadian Asset Management
Two Sigma Investments
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
UBS Group

View all funds holding Theravance Biopharma